Duration of ColdZyme® II

Status Completed

Clinical Trial Summary

The objective of this investigation is to verify that ColdZyme® is deposited onto the throat and estimate the half-life of the ColdZyme® solution in the oropharynx of human volunteers using a log-linear mixed-effects model (LMM).

Clinical Trial Description

The study is an Open Label, Non-Comparative study intended to verify the method used to measure the duration of ColdZyme®. Each participant will be his own control as samples are taken before application of ColdZyme and used as an internal control. Samples will be taken from the oropharyngeal membrane using a cotton swab before application, and 1, 3, 5, 10, 20, and 60 minutes after application. Glycerol will then be extracted from the swabs using water and the concentration of glycerol will be measured. ;

Study Design

Related Conditions & MeSH terms

Common Cold

Clinical Trial Details

NCT number	NCT03901846
Study type	Interventional
Source	Enzymatica AB
Contact
Status	Completed
Phase	N/A
Start date	May 7, 2019
Completion date	July 25, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05269290` - Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections	Phase 3
Completed	`NCT02451163` - DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly	Phase 2
Completed	`NCT01944631` - Iota-Carrageenan Nasal Spray in Common Cold	Phase 4
Completed	`NCT01651715` - Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections	Phase 1/Phase 2
Completed	`NCT00963443` - Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold	Phase 3
Completed	`NCT00778648` - Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms	N/A
Completed	`NCT00065715` - Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)	Phase 3
Completed	`NCT00032500` - Evaluation of Echinacea for the Common Cold	Phase 2
Not yet recruiting	`NCT05070650` - Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold	Phase 3
Completed	`NCT04144491` - Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda	N/A
Not yet recruiting	`NCT04073511` - Herbal Medicine 'Eungyosan' and 'Samsoeum' for Common Cold	N/A
Completed	`NCT03189537` - Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections	Phase 3
Terminated	`NCT01964885` - Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections	Phase 3
Completed	`NCT01277081` - Effect of Paracetamol on the Common Cold	Phase 2
Completed	`NCT01728090` - Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections	Phase 4
Completed	`NCT00405509` - The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years	N/A
Completed	`NCT01033526` - Symptomatic Treatment of Common Cold Symptoms	Phase 4
Completed	`NCT05556148` - Otrivine: Quality of Life (QoL) Impact in a Real-World Setting	Phase 4
Terminated	`NCT03339726` - Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold	Phase 2
Completed	`NCT01361399` - Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold	Phase 3